Logo image of PRN.CA

PROFOUND MEDICAL CORP (PRN.CA) Stock Fundamental Analysis

Canada - TSX:PRN - CA74319B5027 - Common Stock

8 CAD
-1.05 (-11.6%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, PRN scores 4 out of 10 in our fundamental rating. PRN was compared to 16 industry peers in the Health Care Equipment & Supplies industry. The financial health of PRN is average, but there are quite some concerns on its profitability. PRN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

PRN had negative earnings in the past year.
In the past year PRN has reported a negative cash flow from operations.
PRN had negative earnings in each of the past 5 years.
In the past 5 years PRN always reported negative operating cash flow.
PRN.CA Yearly Net Income VS EBIT VS OCF VS FCFPRN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

PRN's Return On Assets of -82.01% is fine compared to the rest of the industry. PRN outperforms 75.00% of its industry peers.
With a decent Return On Equity value of -103.75%, PRN is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -82.01%
ROE -103.75%
ROIC N/A
ROA(3y)-49.72%
ROA(5y)-41.04%
ROE(3y)-64.26%
ROE(5y)-50.62%
ROIC(3y)N/A
ROIC(5y)N/A
PRN.CA Yearly ROA, ROE, ROICPRN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

PRN has a Gross Margin of 69.43%. This is amongst the best in the industry. PRN outperforms 81.25% of its industry peers.
PRN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y2.85%
PRN.CA Yearly Profit, Operating, Gross MarginsPRN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

5

2. Health

2.1 Basic Checks

PRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PRN has more shares outstanding
Compared to 5 years ago, PRN has more shares outstanding
Compared to 1 year ago, PRN has an improved debt to assets ratio.
PRN.CA Yearly Shares OutstandingPRN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PRN.CA Yearly Total Debt VS Total AssetsPRN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PRN has an Altman-Z score of 0.72. This is a bad value and indicates that PRN is not financially healthy and even has some risk of bankruptcy.
PRN has a Altman-Z score of 0.72. This is amongst the best in the industry. PRN outperforms 87.50% of its industry peers.
PRN has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
PRN has a better Debt to Equity ratio (0.12) than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACCN/A
WACC7.95%
PRN.CA Yearly LT Debt VS Equity VS FCFPRN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 8.53 indicates that PRN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 8.53, PRN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
PRN has a Quick Ratio of 7.07. This indicates that PRN is financially healthy and has no problem in meeting its short term obligations.
PRN has a Quick ratio of 7.07. This is amongst the best in the industry. PRN outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 8.53
Quick Ratio 7.07
PRN.CA Yearly Current Assets VS Current LiabilitesPRN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

The earnings per share for PRN have decreased strongly by -19.67% in the last year.
The Revenue has grown by 50.25% in the past year. This is a very strong growth!
Measured over the past years, PRN shows a very strong growth in Revenue. The Revenue has been growing by 20.67% on average per year.
EPS 1Y (TTM)-19.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
Revenue 1Y (TTM)50.25%
Revenue growth 3Y15.83%
Revenue growth 5Y20.67%
Sales Q2Q%-0.99%

3.2 Future

Based on estimates for the next years, PRN will show a very strong growth in Earnings Per Share. The EPS will grow by 26.32% on average per year.
PRN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 74.43% yearly.
EPS Next Y-38.2%
EPS Next 2Y-6.49%
EPS Next 3Y2.89%
EPS Next 5Y26.32%
Revenue Next Year51.68%
Revenue Next 2Y83.42%
Revenue Next 3Y73.26%
Revenue Next 5Y74.43%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRN.CA Yearly Revenue VS EstimatesPRN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
PRN.CA Yearly EPS VS EstimatesPRN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRN. In the last year negative earnings were reported.
Also next year PRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRN.CA Price Earnings VS Forward Price EarningsPRN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRN.CA Per share dataPRN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.49%
EPS Next 3Y2.89%

More info and screens

0

5. Dividend

5.1 Amount

PRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PROFOUND MEDICAL CORP

TSX:PRN (10/10/2025, 7:00:00 PM)

8

-1.05 (-11.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners45.81%
Inst Owner ChangeN/A
Ins Owners17.71%
Ins Owner ChangeN/A
Market Cap240.96M
Analysts80
Price Target15.56 (94.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.7%
Min EPS beat(2)-40.1%
Max EPS beat(2)-27.3%
EPS beat(4)1
Avg EPS beat(4)-13.29%
Min EPS beat(4)-40.1%
Max EPS beat(4)42.88%
EPS beat(8)4
Avg EPS beat(8)-6.05%
EPS beat(12)7
Avg EPS beat(12)-1.83%
EPS beat(16)9
Avg EPS beat(16)-2.03%
Revenue beat(2)0
Avg Revenue beat(2)-31.94%
Min Revenue beat(2)-38.03%
Max Revenue beat(2)-25.86%
Revenue beat(4)0
Avg Revenue beat(4)-17.41%
Min Revenue beat(4)-38.03%
Max Revenue beat(4)-2.68%
Revenue beat(8)1
Avg Revenue beat(8)-15.76%
Revenue beat(12)1
Avg Revenue beat(12)-19.57%
Revenue beat(16)2
Avg Revenue beat(16)-22.34%
PT rev (1m)0%
PT rev (3m)31.75%
EPS NQ rev (1m)6.29%
EPS NQ rev (3m)-7.45%
EPS NY rev (1m)-3.03%
EPS NY rev (3m)-38.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.52
P/FCF N/A
P/OCF N/A
P/B 4.38
P/tB 4.4
EV/EBITDA N/A
EPS(TTM)-2.05
EYN/A
EPS(NY)-1.78
Fwd EYN/A
FCF(TTM)-1.62
FCFYN/A
OCF(TTM)-1.62
OCFYN/A
SpS0.55
BVpS1.83
TBVpS1.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -82.01%
ROE -103.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.43%
FCFM N/A
ROA(3y)-49.72%
ROA(5y)-41.04%
ROE(3y)-64.26%
ROE(5y)-50.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.33%
GM growth 5Y2.85%
F-Score3
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.53
Quick Ratio 7.07
Altman-Z 0.72
F-Score3
WACC7.95%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.71%
EPS Next Y-38.2%
EPS Next 2Y-6.49%
EPS Next 3Y2.89%
EPS Next 5Y26.32%
Revenue 1Y (TTM)50.25%
Revenue growth 3Y15.83%
Revenue growth 5Y20.67%
Sales Q2Q%-0.99%
Revenue Next Year51.68%
Revenue Next 2Y83.42%
Revenue Next 3Y73.26%
Revenue Next 5Y74.43%
EBIT growth 1Y-37.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-26.37%
EBIT Next 3Y6.51%
EBIT Next 5Y30.47%
FCF growth 1Y-48.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.97%
OCF growth 3YN/A
OCF growth 5YN/A